Clin2
NCT07102251Possibly a fitRecruiting

Safety study of HEC-007 injection in healthy and overweight people

Healthy Subjects

This trial tests a new injection, HEC-007, to see if it is safe in healthy adults and in people who are overweight or obese. It may help with weight management and related health issues.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
126 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are a healthy adult aged 18 to 65, or you are overweight or obese with a BMI of 24 or higher.
  • If you are overweight (BMI 24 to 28), you also have at least one condition like prediabetes, high blood pressure, or fatty liver.
  • You have not been diagnosed with type 1 or type 2 diabetes.
  • You agree to use effective birth control for 6 months after the last dose, if you or your partner could become pregnant.
  • You have not used any GLP-1 medicines (like Ozempic) in the last 6 months.
  • You have no history of thyroid cancer or pancreatitis.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06934408Recruiting· Phase 1
Safety study of HRS-5817 injection in healthy adults

This early-phase trial tests the safety and tolerability of a new injection called HRS-5817 in healthy volunteers. It helps researchers understand how the drug moves through the body and what side effects it might have.

Hefei, Anhui
NCT07716241Not yet recruiting· Phase 1
Study of HS-20136-2 for healthy or obese adults

This trial tests a new injection called HS-20136-2. It looks at what happens to the drug in healthy people and in people with obesity. This helps find safe doses and see how the drug works.

Hefei
NCT06886126Recruiting· Phase 2
Testing HDM1005 injection for weight loss in adults with obesity

This study tests an experimental injection called HDM1005 for adults with obesity who do not have diabetes. The goal is to see if it helps with weight loss when combined with diet and exercise.

Nanjing
NCT07376200Recruiting· Phase 1
First-in-human study of a new injection (HEC-151)

This study tests a new injection called HEC-151 in healthy men to see how it affects the body at different single doses. It's one of the first steps to see if the drug is safe and could one day help people with diabetes or related conditions.

Chongqing, Bishan
NCT07776041Not yet recruiting· Phase 1
Study of a new injection for healthy volunteers

This trial tests a new injection called SYH2092 in healthy adults, not for treating a disease. Participation helps researchers understand how the drug works in the body and if it is safe. If you qualify, you may be compensated for your time.

Melbourne, Victoria
NCT07184502Recruiting· Phase 1
Testing a new injection for weight loss in healthy and overweight adults

This trial tests an investigational injection called ZT003 to see if it is safe and how the body processes it. It is for healthy volunteers or those who are overweight or obese, to help understand how this treatment might work.

Brisbane, Queensland

Hear when a new Healthy Subjects trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.